현재 위치:홈 > 뉴스현황
06
29
2020
Chuansha, Shanghai, June 29, 2020. -- Convalife and Medicilon signed a strategic pact, initiating a long-term cooperation between the two companies.
06
16
2020
Date:June 20, 2020 9:00 to 17:00 EST
Location:Virtual Online
06
10
2020
Lamivudine (Brand name: Heganding) comes in 100-mg tablets. It’s a treatment for chronic Heptitis B adult patients with ALT rising, active virus replicating and liver decompensation.
06
04
2020
Congratualtions to Medicilon’s partner, Bio-Thera, on obtaining NMPA’s approval of clinical trials of BAT1308.
06
01
2020
Led by Dr. CHUN-LIN CHEN, the founder and CEO of Shanghai Medicilon Inc., the entreprenuer team in Medicilon received the “Most Improved in the Science and Technology” award presented by Pudong New Area.